EUVIMEDОткрийте EUVIMED
Video/AudioOpen access

Generation of the Early-Gestational Maternal Immune Activation Mouse Model to Assess Prenatal Inflammation on Neurodevelopment

Sydney Camfield, Abril Gaona-Gamboa, Clara L Hibbs, Lindsay N Hayes

Journal of Visualized Experiments · 2026

DOI: 10.3791/70352 ↗

At a glance

Video/Audio in Journal of Visualized Experiments, 2026. Written by Sydney Camfield and 3 co-authors. Institution: Department of Cell Biology, College of Medicine, University of Oklahoma. Major MEDLINE topics: Disease Models, Animal, Inflammation, Neurodevelopmental Disorders. 41 references. The full text is freely available in PubMed Central. Funded by: NIA NIH HHS, NIGMS NIH HHS.

РезюмеSubjectsБиблиографски данниCiteRelated studies

Abstract (original language)

Neurodevelopmental disorders (NDDs) arise from complex interactions between genetic and environmental risk factors, including prenatal immune activation. Maternal immune activation (MIA) in mice is a widely used model to study environmental contributions to NDDs; variability in experimental outcomes limits reproducibility. Here, we present a standardized protocol for inducing MIA during early gestation at embryonic day 9.5 (E9.5) in mice, incorporating multiple quality control metrics to assess immune response and predict pregnancy outcomes. Following administration of polyinosinic:polycytidylic acid (poly(I:C)), maternal serum cytokines are quantified to confirm robust immune activation, allowing an exclusion metric for low responders. Maternal weight trajectories from E0.5 to E12.5 are predictive of litter viability, with dams that produced litter exhibiting characteristic weight-gain patterns distinct from dams that lost a litter. We also observed that the animal vendor significantly influenced maternal immune response and litter viability, while poly(I:C) formulation was not a significant factor. Altogether, the protocol provides strategies to enhance the reproducibility of the early-gestational MIA model and the viability of the offspring by monitoring maternal immune response and weight changes, and by controlling animal vendors, to ultimately study the effect of prenatal immune activation on neurodevelopment.

Subjects

MeSH terms (MEDLINE)

Disease Models, AnimalInflammationNeurodevelopmental DisordersAnimalsFemalePregnancyMicePoly I-CNeurodevelopmentCytokines

Substances

Poly I-CCytokines

Authors and institutions

  • Department of Cell Biology, College of Medicine, University of Oklahoma.
  • Graduate Program in Neuroscience, College of Medicine, University of Oklahoma.
  • Department of Cell Biology, College of Medicine, University of Oklahoma; Graduate Program in Neuroscience, College of Medicine, University of Oklahoma; Lindsay-Hayes@ou.edu.

Funding

  • NIA NIH HHS
  • NIGMS NIH HHS

Cite

APA

Camfield, S., Gaona-Gamboa, A., Hibbs, C. L., & Hayes, L. N. (2026). Generation of the Early-Gestational Maternal Immune Activation Mouse Model to Assess Prenatal Inflammation on Neurodevelopment. Journal of Visualized Experiments. https://doi.org/10.3791/70352

Vancouver

Camfield S, Gaona-Gamboa A, Hibbs CL, Hayes LN. Generation of the Early-Gestational Maternal Immune Activation Mouse Model to Assess Prenatal Inflammation on Neurodevelopment. Journal of Visualized Experiments. 2026. doi:10.3791/70352

BibTeX
@article{Camfield2026,
  author = {Camfield, Sydney and Gaona-Gamboa, Abril and Hibbs, Clara L and Hayes, Lindsay N},
  title = {Generation of the Early-Gestational Maternal Immune Activation Mouse Model to Assess Prenatal Inflammation on Neurodevelopment},
  journal = {Journal of Visualized Experiments},
  year = {2026},
  doi = {10.3791/70352}
}
Start for free →